A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats

Diabetologia

Volumn 43, Issue 6, 2000, Pages 786-793

  Sima, A A F ^a,d   Zhang, W ^a   Xu, G ^a   Sugimoto, K ^a   Guberski, D ^b   Yorek, M A ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Biomedical Research Models Inc   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electrophysiology; Neuropathy; Structural changes; Type I and Type II diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DISEASE SEVERITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE CONDUCTION; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034130913     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051376     Document Type: Article

References (45)

1. 1. Pickup JC, William S (1994) Chronic complications of diabetes. Blackwell Science, London
2. 2. Greene DA, Sima AA, Feldman EL, Stevens MJ (1997) Diabetic neuropathy. In: Rifkin H, Porte D, Sherwin R (eds) Ellenberg and Rifkin Diabetes Mellitus, 5th edn. Appleton & Lange, Stanford, pp 1009-1076
3. 3. Sima AA, Nathaniel V, Bril V, McEwen TA, Greene DA (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364
4. 4. Bril V, Werb MR, Greene DA, Sima AA (1996) Single fiber electromyography in diabetic peripheral polyneuropathy. Muscle Nerve 19: 2-9
5. 5. Ellis EA, Grant MB, Murray FT et al. (1998) Increased NADH oxidase activity in the retina of the BBZ/WOR diabetic rat. Free Radic Biol Med 24: 111-120
6. DR-rat: A model for type II diabetic neuropathy. Exp Clin Endocrinol Diabetes 105: 63-64
7. 7. Mordes JP, Greiner DL, Rossini AA (1996) Animal models of autoimmune diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes Mellitus. A fundamental and clinical text. Lippincott-Raven, Philadelphia, pp 349-360
8. 8. Marliss EB, Nakhooda AF, Poussier P, Sima AA (1982) The diabetic syndrome of the BB-Wistar rat. Possible relevance to Type I (insulin dependent) diabetes in man. Diabetologia 22: 225-232
9. 9. Sima AA, Bouchier M, Christensen H (1983) Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat, a possible early correlate of human diabetic neuropathy. Ann Neurol 13: 264-272
10. 10. Sima AA, Lattimer SA, Yagihashi S, Greene DA (1986) "Axo-glial dysjunction": a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic BB-rat. J Clin Invest 77: 474-484
11. 11. Sima AA, Brismar T (1985) Reversible diabetic nerve dysfunction. Structural correlates to electrophysiological abnormalities. Ann Neurol 18: 21-29
12. 12. Sima AA (1993) The natural history of diabetic neuropathy in the BB-rat. In: Sharma AK (ed) Diabetes mellitus and its complications - an update. Macmillan India Limited, Delhi, pp 315-325
13. 13. Kamijo M, Merry AC, Cherian PV et al. (1996) Nerve fiber regeneration following axotomy in the diabetic BB/W-rat. The effect of ARI-treatment. J Diabetes Complications 10: 183-191
14. 14. Sima AA, Ristic H, Merry A et al. (1996) Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J Clin Invest 97: 1900-1907
15. +-AT-Pase in rats maintained on a diet containing L-fucose. Reversal by myo-inositol supplementation. Diabetes 42: 1401-1406
16. 16. Yamamoto K, Merry AC, Sima AA (1996) An orderly development of paranodal axoglial junctions and bracelets of Nageotte in the rat sural nerve. Dev Brain Res 96: 36-45
17. 17. Stevens MJ, Lattimer SA, Kamijo M et al. (1993) Osmotically induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36: 608-614
18. 18. Greene DA, Chakrabarti S, Lattimer SA, Sima AA (1987) Role of sorbitol accumulation and myoinositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic biobreeding rat. J Clin Invest 79: 1479-1485
19. 19. Yagihashi S, Sugimoto K, Wada R (1994) Different neuropathic patterns between type I and type II diabetic animal models. In: Sokamoto N, Alberti KG, Hotta N (eds) Pathogenesis and treatment of NIDDM and its related problems. Elsevier Science, Amsterdam, pp 401-405
20. 20. Yagihashi S, Wada R, Kamijo M, Nagai K (1993) Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 68: 296-307
21. 21. Sima AA, Sugimoto K (1999) Experimental diabetic neuropathy - an update. Diabetologia 42 773-788
22. 22. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329 977-986
23. 23. Cameron NE, Cotter MA (1994) The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diab Met Rev 10: 189-224
24. 24. Cameron NE, Cotter MA (1999) Oxidative stress and abnormal lipid metabolism in diabetic complications. In: Sima AA, Shafrir E (eds) Frontiers in Animal Diabetes Research. Chronic Complication in Diabetes, vol 1. Harwood, Amsterdam, pp 97-130
25. 25. Sima AA, Prashar A, Zhang W-X et al. (1990) Preventive effect of long term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic bio-breeding-rat. J Clin Invest 85: 1410-1420
26. 26. Sima AA, Greene DA (1996) Nerve morphometry - a valuable tool in the assessment of natural history and electrophysiological correlates in diabetic neuropathy. In: Sharma AK (ed) Morphometry, Applications to Medical Sciences. MacMillan, Delhi, pp 122-133
27. +-channel displacement is associated with nerve conduction slowing in the chronically diabetic BB/W-rat. Prevention by an aldose reductase inhibitor. J Diabetes Complications 10: 192-200
28. 28. Cherian PV, Brosius FC III, Greene DA, Sima AA (1996) Expression and localization of GLUT1 and GLUT3 in peripheral nerve of diabetic BB/W-rat. Diabetologia 39[Suppl 1]:A172 (Abstract)
29. 29. Brismar T, Sima AA (1981) Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat. Acta Physiol Scand 113: 499-506
30. 30. Sugimoto K, Zhang W, Xu G, Sima AA (1999) Localization of insulin receptor isoforms in rat peripheral nerve. Diabetes 48:[Suppl 1]A151 (Abstract)
31. 31. Sima AA, Zhang W, Xu G (1999) Long-term effect of C-peptide treatment on type 1 diabetic neuropathy. Diabetes 48:[Suppl 1]A149 (Abstract)
32. 32. Rigler R, Pramanik A, Jonasson P et al. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96: 13378-13383
33. 33. Hoogwert B, Bantle J, Gaenlen H et al. (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122-125
34. 34. Jensen ME, Messina EJ (1999) C-peptide induces a concentration-dependent dilatation of skeletal muscles arterioles only in presence of insulin. Am J Physiol 276:H1223-H1228
35. 35. Sima AA, Srinivas PR, Kammaraju S et al. (1998). Enhancement of insulin receptor activity by C-peptide. Diabetologia 41:A177 (Abstract)
36. 36. Ischii DN (1995) Implications of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Rev 20: 47-67
37. 37. Fernyhough P, Willars GB, Lindsay RM, Tomlinson DR (1993) Insulin and insulin-like growth factor I enhances regeneration in cultured adult rat sensory neurons. Brain Res 607: 117-124
38. 38. Recio-Pinto E, Lang FF, Ischii DN (1984) Insulin and insulin growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc Natl Acad Sci USA 81: 2562-2566
39. 39. Powell HC, Garrett RS, Kador PF, Mizisin AP (1991) Fine structural localization of aldose reductase and ouabain-sensitive K( + )-dependent p-nitro-phenylphosphatase in rat peripheral nerve. Acta Neuropathol (Berl) 81: 529-539
40. 40. Chakrabarti S, Sima AA, Nakajima S et al. (1987) Aldose reductase in the BB-rat. Isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 30: 244-251
41. 41. Magnani P, Cherian PV, Gould GW et al. (1996) Glucose transporters in rat peripheral nerve: paranodal expression of GLUT I and GLUT 3. Metabolism 45: 1466-1473
42. 42. Menegoz M, Gaspar P, LeBert M et al. (1997) Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19: 319-331
43. + channels. Neuron 24: 1037-1047
44. 44. Davis, JQ, Lambert S, Bernett V (1996) Molecular composition of the node of Ranvier: identification of ankyrinbinding cell adhesion molecules neurofascin (mucin + / third FN III domain-) and NrCAM at nodal axon segments. J Cell Biol 135: 1355-1367
45. 45. Einheber S, Zanazzi G, Ching W et al. (1997) The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate like paranodal junctions that assemble during myelination. J Cell Biol 139: 1495-1506